Effects of Obesity and Weight Loss on the Functional Properties of Early Outgrowth Endothelial Progenitor Cells

Journal of the American College of Cardiology

Volumn 55, Issue 4, 2010, Pages 357-367

  Heida, Nana Maria ^a   Müller, Jan Peter ^a   Cheng, I Fen ^a   Leifheit Nestler, Maren ^a   Faustin, Vivien ^a   Riggert, Joachim ^a   Hasenfuss, Gerd ^a   Konstantinides, Stavros ^a   Schäfer, Katrin ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

endothelial progenitor cells; obesity; signal transduction; weight loss

Indexed keywords

INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL ADHESION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; LEG ISCHEMIA; MALE; OBESITY; PARAMETER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL; WEIGHT REDUCTION;

ADULT; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS; WEIGHT LOSS;

EID: 74049152789     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.031     Document Type: Article

References (30)

1. Cassidy A.E., Bielak L.F., Zhou Y., et al. Progression of subclinical coronary atherosclerosis: does obesity make a difference?. Circulation 111 (2005) 1877-1882
2. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
3. Wolk R., Berger P., Lennon R.J., Brilakis E.S., and Somers V.K. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 108 (2003) 2206-2211
4. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
5. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
6. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
7. Hirschi K.K., Ingram D.A., and Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28 (2008) 1584-1595
8. Schroeter M.R., Leifheit M., Sudholt P., et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 103 (2008) 536-544
9. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
10. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
11. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39 (2005) 733-742
12. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
13. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
14. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
15. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
16. Loomans C.J., de Koning E.J., Staal F.J., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
17. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
18. Muller-Ehmsen J., Braun D., Schneider T., et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J 29 (2008) 1560-1568
19. Rehman J., Li J., Parvathaneni L., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43 (2004) 2314-2318
20. Kondo T., Hayashi M., Takeshita K., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24 (2004) 1442-1447
21. Prater D.N., Case J., Ingram D.A., and Yoder M.C. Working hypothesis to redefine endothelial progenitor cells. Leukemia 21 (2007) 1141-1149
22. Li T.S., Furutani A., Takahashi M., et al. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am J Physiol Heart Circ Physiol 290 (2006) H1362-H1369
23. Awad O., Jiao C., Ma N., Dunnwald M., and Schatteman G.C. Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23 (2005) 575-583
24. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 164 (2004) 457-466
25. Rousseau S., Houle F., Landry J., and Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15 (1997) 2169-2177
26. Qamirani E., Ren Y., Kuo L., and Hein T.W. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 25 (2005) 995-1001
27. Khreiss T., Jozsef L., Potempa L.A., and Filep J.G. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109 (2004) 2016-2022
28. Lim M.Y., Wang H., Kapoun A.M., et al. p38 inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J Mol Cell Cardiol 37 (2004) 1111-1114
29. Seeger F.H., Haendeler J., Walter D.H., et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 (2005) 1184-1191
30. Haskell W.L., Lee I.M., Pate R.R., et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39 (2007) 1423-1434